FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008934746> ?p ?o ?g. }

• W3008934746 endingPage "555" @default.
• W3008934746 startingPage "545" @default.
• W3008934746 abstract "This study aimed to assess the serum levels of intracellular adhesion molecule (sICAM-1), and vascular cell adhesion molecule (sVCAM-1), in the first psychotic episode schizophrenia (SZ) patients, before and after six months of antipsychotic treatment.The study included 50 patients with a first hospitalization for SZ and 50 healthy control subjects that were patient-matched regarding age, gender, body mass index and smoking status. The evaluation included the presence of cardiovascular risk factors, measurements of systolic and diastolic blood pressure, body mass index, smoking status, ankle-brachial index, carotid intima-media thickness, and echocardiography. The Brief Psychiatric Rating Scale (BPRS) score was calculated for the patients. The plasma levels of fasting glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, sICAM-1 and sVCAM-1 were determined at baseline in all subjects and after six months of antipsychotic treatment. Thirty patients (60%) were treated with olanzapine and 20 (40%) with risperidone.The average age of patients experiencing their first episode of SZ was 29.7±6.6 years, and 23 (46%) were men. The initial sICAM-1 levels of the patients were lower than those of the control group (P<0.0001), and increased after treatment (P=0.02), but remained lower than in the healthy controls (P=0.026). The initial levels of sVCAM-1 levels were higher in the patients (P<0.0001) and decreased after treatment (P<0.0001) to values that were similar to those of the control group (P=0.39). The only independent predictor of a baseline BPRS over 120 was the baseline sVCAM-1 level (P<0.0001). Antipsychotic treatment induced significant decreases in BPRS score (P<0.0001), in systolic (P=0.005) and diastolic (P<0.0001) blood pressure, in HDL-c (P=0.02), as well as significant increases in blood glucose (P<0.01) and LDL-c (P<0.001), with no differences between olanzapine and risperidone.In the patients experiencing an FEP of SZ, the levels of sICAM-1 were lower, while the levels of sVCAM-1 were higher than in the healthy control subjects. The antipsychotics used in the treatment of schizophrenia increased sICAM-1 and decreased sVCAM. The baseline level of sVCAM-1 was an independent predictor of a BPRS score >120 at baseline." @default.
• W3008934746 created "2020-03-06" @default.
• W3008934746 creator A5003137819 @default.
• W3008934746 creator A5003249473 @default.
• W3008934746 creator A5008756378 @default.
• W3008934746 creator A5021359595 @default.
• W3008934746 creator A5027106464 @default.
• W3008934746 creator A5048662890 @default.
• W3008934746 creator A5051889444 @default.
• W3008934746 creator A5057828687 @default.
• W3008934746 creator A5060991216 @default.
• W3008934746 creator A5066154590 @default.
• W3008934746 creator A5083279858 @default.
• W3008934746 creator A5089574369 @default.
• W3008934746 date "2020-02-01" @default.
• W3008934746 modified "2023-09-27" @default.
• W3008934746 title "<p>The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia</p>" @default.
• W3008934746 cites W1964022660 @default.
• W3008934746 cites W1965266743 @default.
• W3008934746 cites W1969833165 @default.
• W3008934746 cites W1971351668 @default.
• W3008934746 cites W1979692345 @default.
• W3008934746 cites W1981674335 @default.
• W3008934746 cites W1982618948 @default.
• W3008934746 cites W2001640154 @default.
• W3008934746 cites W2016280898 @default.
• W3008934746 cites W2038114663 @default.
• W3008934746 cites W2064520145 @default.
• W3008934746 cites W2081921819 @default.
• W3008934746 cites W2087709083 @default.
• W3008934746 cites W2088104264 @default.
• W3008934746 cites W2095675080 @default.
• W3008934746 cites W2096457914 @default.
• W3008934746 cites W2101099004 @default.
• W3008934746 cites W2121637331 @default.
• W3008934746 cites W2135178324 @default.
• W3008934746 cites W2166833739 @default.
• W3008934746 cites W2168058079 @default.
• W3008934746 cites W2277855500 @default.
• W3008934746 cites W2300880694 @default.
• W3008934746 cites W2399060753 @default.
• W3008934746 cites W2758831103 @default.
• W3008934746 cites W2888923340 @default.
• W3008934746 cites W2890364529 @default.
• W3008934746 cites W2900366804 @default.
• W3008934746 cites W2912780365 @default.
• W3008934746 doi "https://doi.org/10.2147/ndt.s240349" @default.
• W3008934746 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7047995" @default.
• W3008934746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32158214" @default.
• W3008934746 hasPublicationYear "2020" @default.
• W3008934746 type Work @default.
• W3008934746 sameAs 3008934746 @default.
• W3008934746 citedByCount "10" @default.
• W3008934746 countsByYear W30089347462020 @default.
• W3008934746 countsByYear W30089347462021 @default.
• W3008934746 countsByYear W30089347462022 @default.
• W3008934746 countsByYear W30089347462023 @default.
• W3008934746 crossrefType "journal-article" @default.
• W3008934746 hasAuthorship W3008934746A5003137819 @default.
• W3008934746 hasAuthorship W3008934746A5003249473 @default.
• W3008934746 hasAuthorship W3008934746A5008756378 @default.
• W3008934746 hasAuthorship W3008934746A5021359595 @default.
• W3008934746 hasAuthorship W3008934746A5027106464 @default.
• W3008934746 hasAuthorship W3008934746A5048662890 @default.
• W3008934746 hasAuthorship W3008934746A5051889444 @default.
• W3008934746 hasAuthorship W3008934746A5057828687 @default.
• W3008934746 hasAuthorship W3008934746A5060991216 @default.
• W3008934746 hasAuthorship W3008934746A5066154590 @default.
• W3008934746 hasAuthorship W3008934746A5083279858 @default.
• W3008934746 hasAuthorship W3008934746A5089574369 @default.
• W3008934746 hasBestOaLocation W30089347461 @default.
• W3008934746 hasConcept C118552586 @default.
• W3008934746 hasConcept C126322002 @default.
• W3008934746 hasConcept C134018914 @default.
• W3008934746 hasConcept C164705383 @default.
• W3008934746 hasConcept C2776412080 @default.
• W3008934746 hasConcept C2776619155 @default.
• W3008934746 hasConcept C2778528637 @default.
• W3008934746 hasConcept C2779727114 @default.
• W3008934746 hasConcept C2780057945 @default.
• W3008934746 hasConcept C2780221984 @default.
• W3008934746 hasConcept C2780494398 @default.
• W3008934746 hasConcept C71924100 @default.
• W3008934746 hasConcept C84393581 @default.
• W3008934746 hasConcept C90924648 @default.
• W3008934746 hasConceptScore W3008934746C118552586 @default.
• W3008934746 hasConceptScore W3008934746C126322002 @default.
• W3008934746 hasConceptScore W3008934746C134018914 @default.
• W3008934746 hasConceptScore W3008934746C164705383 @default.
• W3008934746 hasConceptScore W3008934746C2776412080 @default.
• W3008934746 hasConceptScore W3008934746C2776619155 @default.
• W3008934746 hasConceptScore W3008934746C2778528637 @default.
• W3008934746 hasConceptScore W3008934746C2779727114 @default.
• W3008934746 hasConceptScore W3008934746C2780057945 @default.
• W3008934746 hasConceptScore W3008934746C2780221984 @default.
• W3008934746 hasConceptScore W3008934746C2780494398 @default.
• W3008934746 hasConceptScore W3008934746C71924100 @default.
• W3008934746 hasConceptScore W3008934746C84393581 @default.

• next